Search - tctmd.com

Displaying 401 - 420 of 2035

Sort: Relevancy | Date

Presentation TCT 2015

Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment

Presenter: Robert A. Byrne, Stefan K. James, Fernando Alfonso

October 11, 2015

Presentation TCT 2015

How Was the Case Treated

Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis

Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Presenter: Robert A. Byrne, Stefan K. James, Donald Cutlip

October 11, 2015

Presentation TCT 2015

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Presenter: Robert A. Byrne, Stefan K. James, Renu Virmani

October 11, 2015

Presentation TCT 2015

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

Presenter: Robert A. Byrne, Stefan K. James

October 11, 2015

Presentation TCT 2015

How Was This Patient Treated?

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

Presentation TCT 2015

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

How the Case Was Treated

Presenter: Kevin J. Beatt, Craig R. Smith, Javier Escaned

October 11, 2015

Presentation TCT 2015

Case Presentation Pretreatment: MVD Disease With Intermediate SYNTAX Score: How Should This Patient Be Treated?

Presenter: Kevin J. Beatt, Craig R. Smith, Javier Escaned

October 11, 2015

Presentation TCT 2015

Assessment and Implications of Surgical Inoperability: Who Is at High Risk?

Presenter: Kevin J. Beatt, Craig R. Smith, Robert W. Yeh

October 11, 2015

Presentation TCT 2015

Stents in CTO: If I Get It Open, Will It Stay Open?

Presenter: Etsuo Tsuchikane, Gerald S. Werner, Sunao Nakamura

October 11, 2015

Presentation TCT 2015

Functional Risk Scoring: Fame 3 and Beyond

Presenter: Kevin J. Beatt, Craig R. Smith, William F. Fearon

October 11, 2015

Presentation TCT 2015

Are Risk Scores Practical and Useful to Differentiate PCI vs CABG?

Presenter: Kevin J. Beatt, Craig R. Smith, Davide Capodanno

October 11, 2015

Presentation TCT 2015

The SYNTAX Score in Clinical Practice: Promise and Pitfalls

Presenter: Kevin J. Beatt, Craig R. Smith, Philippe Généreux

October 11, 2015

Presentation TCT 2015

Critical Analysis of Current Guidelines on Multivessel Revascularization: Are They Up to Date?

Presenter: Kevin J. Beatt, Craig R. Smith, Marie-Claude Morice

October 11, 2015

Presentation TCT 2015

In Which Patients (if Any) Should BMS Be Used in 2015? Evidence and Common Sense

Presenter: John A. Bittl, E. Magnus Ohman, Marco Valgimigli

October 11, 2015

Presentation TCT 2015

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? No, the Risks Are Real and There Is No Evidence for Benefit!

Presenter: John A. Bittl, E. Magnus Ohman, Jorge F. Saucedo

October 11, 2015

Advertisement

Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment

How Was the Case Treated

Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

How Was This Patient Treated?

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

How the Case Was Treated

Case Presentation Pretreatment: MVD Disease With Intermediate SYNTAX Score: How Should This Patient Be Treated?

Assessment and Implications of Surgical Inoperability: Who Is at High Risk?

Stents in CTO: If I Get It Open, Will It Stay Open?

Functional Risk Scoring: Fame 3 and Beyond

Are Risk Scores Practical and Useful to Differentiate PCI vs CABG?

The SYNTAX Score in Clinical Practice: Promise and Pitfalls

Critical Analysis of Current Guidelines on Multivessel Revascularization: Are They Up to Date?

In Which Patients (if Any) Should BMS Be Used in 2015? Evidence and Common Sense

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? No, the Risks Are Real and There Is No Evidence for Benefit!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content